Paper Details

  1. Home
  2. Paper Details

The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages.

Author: DingNing, FengLixia, LiJiao, LinYufu, LiuYalu, PanZhengying, PingLingyan, ShiCunzhen, ShiYunfei, SongYuqin, WangXing, ZhuJun

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study explores the immunomodulatory effects of Bruton's tyrosine kinase (Btk) inhibitors on macrophages, contributing to the drug's effectiveness in treating hematologic malignancies. The study found that Btk inhibition suppresses production of chemokines and cytokines by macrophages, impacting tumor cell adhesion, invasion, and migration. These findings suggest a novel mechanism of action for Btk inhibitors, potentially extending their therapeutic value beyond B-cell lymphomas.
Paper Details　
Original Abstract of the Article :
The Bruton's tyrosine kinase (Btk) inhibitor ibrutinib has demonstrated promising efficacy in a variety of hematologic malignancies. However, the precise mechanism of action of the drug remains to be fully elucidated. Tumor-infiltrating macrophages presented in the tumor microenvironment have been s...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503608/

データ提供：米国国立医学図書館（NLM）

Ibrutinib: A New Weapon in the Desert of Lymphoma

The desert of lymphoma is a formidable landscape, where malignant B cells proliferate, threatening the health of the body. This study examines the promising role of ibrutinib, a Bruton's tyrosine kinase (Btk) inhibitor, in combating this type of cancer.

A New Oasis in the Desert: Ibrutinib's Potential

The study explores the multifaceted mechanisms by which ibrutinib exerts its therapeutic effects. Beyond directly targeting B cells, ibrutinib demonstrates immunomodulatory effects, influencing the behavior of tumor-infiltrating macrophages. By suppressing the production of pro-inflammatory cytokines and chemokines, ibrutinib can effectively disrupt the tumor microenvironment, hindering the growth and spread of lymphoma cells.

Fighting for Survival in the Desert: The Importance of Immunomodulatory Therapies

This study highlights the potential of immunomodulatory therapies, like ibrutinib, to fight cancer by targeting both the malignant cells and the surrounding environment. This approach offers a promising avenue for treating lymphoma and potentially other cancers, providing new hope for patients battling these devastating diseases.

Dr.Camel's Conclusion

This study is like finding a new weapon in the desert of lymphoma. Ibrutinib's immunomodulatory effects, in addition to its direct cytotoxic action, offer a promising approach to fighting this type of cancer. It is a beacon of hope in the ongoing search for effective cancer treatments.

Date :
  1. Date Completed 2018-06-07
  2. Date Revised 2021-12-04
Further Info :

Pubmed ID

28424405

DOI: Digital Object Identifier

PMC5503608

Related Literature

Article Analysis
・Effects of ibrutinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.